Amyris Launches Terasana Clinical Clean Skincare Brand

▴ Amyris Launches Terasana Clinical Clean Skincare Brand
Latest Pharma News Update

Amyris, Inc., a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the launch of Terasana™ Clinical, a clean skincare brand. Today's launch represents the first of three highly anticipated brand launches Amyris will launch this summer.

Terasana Clinical's first skincare product, Clear + Control Healthy Skin Serum, addresses dry skin, skin flaking, irritation and redness with its moisturizing and anti-inflammatory properties which are designed to clear and balance the skin's appearance. Clear + Control Healthy Skin Serum is a patented formulation that combines two of Amyris' sustainably sourced ingredients, Squalane and Cannabigerol (CBG).

Squalane is Amyris' high-performance moisturizer that has demonstrated skin therapy benefits in clinical and consumer studies. It contributes to skin health by improving the skin's microbiome and enabling the penetration of cannabinoids and other skin care actives to enhance product performance. Amyris' CBG is a powerful anti-inflammatory and anti-microbial non-psychoactive (no THC) minor cannabinoid. Both Squalane and CBG are developed through Amyris' proprietary Lab-to-Market™ science and technology process.

A clinical study conducted with Clear + Control Healthy Skin Serum demonstrated a 92% reduction of blemishes after four weeks with results based on self-assessments by participants with dry skin, skin flaking, irritation, and redness. The study demonstrated that the anti-inflammatory and anti-microbial properties of CBG combined with Squalane improves and nourishes the skin by balancing the skin's microbiome. Compared to top competitive products that address acne and other common skin care issues, the Terasana Clinical formulation reduces inflammation more quickly and more effectively.

Dr Mamina Turegano MD, Triple-Board Certified Dermatologist and Terasana Clinical Brand Ambassador commented, "I am excited to be involved with Terasana Clinical. This is the only skincare brand I know of that combines highly effective, proven ingredients to clear blemishes and breakouts quickly while also nourishing the skin at the same time. The primary ingredients in Clear + Control Healthy Skin Serum, Squalane and CBG, are sustainably sourced and have been clinically tested. The innovative technology used to develop this product provides consumers a chance to experience clear skin with reduced concern for irritation or dryness."

"CBG has a variety of proven skin benefits and through our well-established fermentation technology, we are able to manufacture CBG at scale and at a much lower cost than existing alternatives," said John Melo, President and Chief Executive Officer of Amyris. "We believe that clean CBG has opened up new avenues for innovation in sustainable and effective skincare and that it has the potential to be a breakthrough in addressing the acne market. We are on track to launch three new clean beauty consumer brands this month which is a testament to the consistent performance and execution by our team. We continue to build on our current sales growth momentum in the third quarter and expect the new brands and consumer activity to contribute significant new revenue during the second half of this year."

Tags : #Amyris #Terasana #Skincarebrand #smitakumar #medicircle

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
Reducing Stigma, One Story at a Time: Media's Role in Mental HealthMay 07, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
Akshay Tritiya Parna Mahotsav is to be held in the cityMay 04, 2024
Bharti Singh's Battle with Gallstones: Symptoms, Precautions, and Natural RemediesMay 04, 2024
Empowering Women's Health: New Mammogram GuidelinesMay 04, 2024
Rising Temperatures, Rising Risks: Addressing the Challenges of Heat StressMay 04, 2024
Gynoveda, India's First Ayurveda Fertility Company, Expands Reach with New Clinic in Pune, Set to Open 100 Clinics Across India by 2027May 03, 2024
Aptus Value Housing Finance India Limited, a leading Housing Finance Company has declared its financial results for the year ended March 31, 2024. FY 24 ResultsMay 03, 2024
TIPS FOR PREGNANCY CARE DURING SUMMERMay 03, 2024
The deadly intersection: TB and tobacco smoking co-epidemics in Indonesia Dr TARA SINGH BAM – CNSMay 03, 2024